Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
962.5 USD | -0.39% |
|
-0.57% | +9.59% |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Mar. 25 | Regeneron Shares Down After FDA Letter Questioning Application for Potential Lymphoma Treatment | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock
- Equities
- Stock Regeneron Pharmaceuticals, Inc. - Nasdaq
- Revisions Regeneron Pharmaceuticals, Inc.